GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hunan Fangsheng Pharmaceutical Co Ltd (SHSE:603998) » Definitions » Debt-to-Asset

Hunan Fangsheng Pharmaceutical Co (SHSE:603998) Debt-to-Asset : 0.22 (As of Sep. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Hunan Fangsheng Pharmaceutical Co Debt-to-Asset?

Hunan Fangsheng Pharmaceutical Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥591 Mil. Hunan Fangsheng Pharmaceutical Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ¥117 Mil. Hunan Fangsheng Pharmaceutical Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was ¥3,286 Mil. Hunan Fangsheng Pharmaceutical Co's debt to asset for the quarter that ended in Sep. 2024 was 0.22.


Hunan Fangsheng Pharmaceutical Co Debt-to-Asset Historical Data

The historical data trend for Hunan Fangsheng Pharmaceutical Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hunan Fangsheng Pharmaceutical Co Debt-to-Asset Chart

Hunan Fangsheng Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.22 0.20 0.18 0.22

Hunan Fangsheng Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.22 0.22 0.23 0.24 0.22

Competitive Comparison of Hunan Fangsheng Pharmaceutical Co's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Hunan Fangsheng Pharmaceutical Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hunan Fangsheng Pharmaceutical Co's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hunan Fangsheng Pharmaceutical Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Hunan Fangsheng Pharmaceutical Co's Debt-to-Asset falls into.



Hunan Fangsheng Pharmaceutical Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Hunan Fangsheng Pharmaceutical Co's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(505.697 + 174.005) / 3080.986
=0.22

Hunan Fangsheng Pharmaceutical Co's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(590.825 + 117.14) / 3286.165
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hunan Fangsheng Pharmaceutical Co  (SHSE:603998) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Hunan Fangsheng Pharmaceutical Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Hunan Fangsheng Pharmaceutical Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Hunan Fangsheng Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 789, Lusong Road, Changsha High-tech Zone, Changsha, CHN
Hunan Fangsheng Pharmaceutical Co Ltd is engaged in pharmaceutical business. The company's business scope covers the production and sales of tablets, capsules, granules, oral suspension, powder, suppository, powder-injection, tinctures, spray lotion, small volume injections, and bulk pharmaceutical chemicals. Its product offerings include Cefixime Tablets, Cefpiramide for Injection, Cefprozil Tablets, Fleroxacin Dispersible Tablets, and others.
Executives
He Shi senior management
Xiao Han Qing senior management
Liu Xin He senior management
Chen Bo Director
Chen Ai Chun Director
Li Zhi Heng senior management
Zhou Wei En senior management
Zhang Qing Hua Director
Huang Min Director
Zhou Xiao Li senior management
Fang Jin Cheng Director
Fang Chuan Long Supervisors
Tan Yuan Ming Director

Hunan Fangsheng Pharmaceutical Co Headlines

No Headlines